Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Recombinant Human Albumin Injection
BIOLOGICAL
4 trials
Sponsors
The First Hospital of Jilin University
, Tonghua Anrate Biopharmaceutical Co., Ltd.
Conditions
Ascites
Hepatic Ascites
Phase 1
Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.
Completed
NCT04641364
The First Hospital of Jilin University
Ascites
Start: 2019-06-24
End: 2020-05-06
Updated: 2020-11-23
Phase Ib of Recombinant Human Albumin Injection
Completed
NCT04701697
The First Hospital of Jilin University
Ascites
Start: 2020-03-15
End: 2020-10-25
Updated: 2021-01-08
Phase 2
Phase II/III of Recombinant Human Albumin Injection
Completed
NCT06411743
The First Hospital of Jilin University
Hepatic Ascites
Start: 2021-09-07
End: 2022-08-15
Updated: 2024-05-13
Phase 3
A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites
Completed
NCT06911554
Tonghua Anrate Biopharmaceutical Co., Ltd.
Hepatic Ascites
Start: 2023-06-16
End: 2024-09-27
Updated: 2025-04-04
Related Papers
A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascites
Hepatology International
2025-07-23
3 citations